Clinical Trial: Efficacy and Safety of First-Line Eradication of Helicobacter pylori Infection Using a Dual Therapy Regimen of Glutaric Acid Linarasenate Capsules and Amoxicillin Compared to a Quadruple Therapy Regimen Including Bismuth: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Controlled Study (China)

China, Oct. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of First-Line Eradication of Helicobacter pylori Infection Using a Dual Therapy Regimen of Glutaric Acid Linarasenate Capsules and Amoxicillin Compared to a Quadruple Therapy Regimen Including Bismuth: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Controlled Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135257

Registration Time: 2026/10/27

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of the Air Force Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348695

P...